BACKGROUND: Low concentrations of circulating vitamin D are common with obesity and may represent a potential mechanism explaining the elevated risk of certain cancers and cardiovascular outcomes observed in individuals who are overweight or obese. OBJECTIVE: The objective of this study was to investigate the effects of 12 mo of weight loss through caloric restriction, exercise intervention, or both on serum 25-hydroxyvitamin D [25(OH)D] concentrations. DESIGN:Overweight and obese postmenopausal women (n = 439) were randomly assigned to 1 of 4 groups: 1) diet modification (n = 118), 2) exercise (n = 117), 3) diet + exercise (n = 117), or 4) control (n = 87). The diet intervention was a group-based reduced-calorie program with a 10% weight-loss goal. The exercise intervention consisted of 45 min of moderate-to-vigorous intensity aerobic activity daily for 5 d/wk. Serum 25(OH)D concentrations were measured by using a competitive chemiluminescent immunoassay at baseline and 12 mo. RESULTS: No significant change in serum 25(OH)D was found between the intervention and control groups. Women who lost <5%, 5-9.9%, 10-14.9%, or ≥15% of baseline weight had mean increases in 25(OH)D of 2.1, 2.7, 3.3, and 7.7 ng/mL, respectively (P for trend = 0.002). Baseline vitamin D status did not modify the effect of the interventions on weight loss or body-composition changes at the 12-mo follow-up. CONCLUSION: A greater degree of weight loss, achieved through either a reduced-calorie diet or increased exercise, is associated with increased circulating 25(OH)D concentrations. This trial is registered at clinicaltrials.gov as NCT00470119.
RCT Entities:
BACKGROUND: Low concentrations of circulating vitamin D are common with obesity and may represent a potential mechanism explaining the elevated risk of certain cancers and cardiovascular outcomes observed in individuals who are overweight or obese. OBJECTIVE: The objective of this study was to investigate the effects of 12 mo of weight loss through caloric restriction, exercise intervention, or both on serum 25-hydroxyvitamin D [25(OH)D] concentrations. DESIGN: Overweight and obese postmenopausal women (n = 439) were randomly assigned to 1 of 4 groups: 1) diet modification (n = 118), 2) exercise (n = 117), 3) diet + exercise (n = 117), or 4) control (n = 87). The diet intervention was a group-based reduced-calorie program with a 10% weight-loss goal. The exercise intervention consisted of 45 min of moderate-to-vigorous intensity aerobic activity daily for 5 d/wk. Serum 25(OH)D concentrations were measured by using a competitive chemiluminescent immunoassay at baseline and 12 mo. RESULTS: No significant change in serum 25(OH)D was found between the intervention and control groups. Women who lost <5%, 5-9.9%, 10-14.9%, or ≥15% of baseline weight had mean increases in 25(OH)D of 2.1, 2.7, 3.3, and 7.7 ng/mL, respectively (P for trend = 0.002). Baseline vitamin D status did not modify the effect of the interventions on weight loss or body-composition changes at the 12-mo follow-up. CONCLUSION: A greater degree of weight loss, achieved through either a reduced-calorie diet or increased exercise, is associated with increased circulating 25(OH)D concentrations. This trial is registered at clinicaltrials.gov as NCT00470119.
Authors: P A Hollander; S C Elbein; I B Hirsch; D Kelley; J McGill; T Taylor; S R Weiss; S E Crockett; R A Kaplan; J Comstock; C P Lucas; P A Lodewick; W Canovatchel; J Chung; J Hauptman Journal: Diabetes Care Date: 1998-08 Impact factor: 19.112
Authors: Harald Dobnig; Stefan Pilz; Hubert Scharnagl; Wilfried Renner; Ursula Seelhorst; Britta Wellnitz; Jürgen Kinkeldei; Bernhard O Boehm; Gisela Weihrauch; Winfried Maerz Journal: Arch Intern Med Date: 2008-06-23
Authors: Srujana Rayalam; Mary Anne Della-Fera; Suresh Ambati; Jeong-Yeh Yang; Hea Jin Park; Clifton A Baile Journal: Obesity (Silver Spring) Date: 2008-01-17 Impact factor: 5.002
Authors: Natalia E Schlabritz-Loutsevitch; Anthony G Comuzzie; Michael M Mahaney; Gene B Hubbard; Edward J Dick; Mehmet Kocak; Sonali Gupta; Maira Carrillo; Mauro Schenone; Arnold Postlethwaite; Andrzej Slominski Journal: Comp Med Date: 2016-04 Impact factor: 0.982
Authors: Melissa A Kluczynski; Jean Wactawski-Wende; Mary E Platek; Carol A DeNysschen; Kathleen M Hovey; Amy E Millen Journal: J Nutr Date: 2012-07-25 Impact factor: 4.798
Authors: Rebecca J Moon; Sarah R Crozier; Elaine M Dennison; Justin H Davies; Sian M Robinson; Hazel M Inskip; Keith M Godfrey; Cyrus Cooper; Nicholas C Harvey Journal: Am J Clin Nutr Date: 2015-09-23 Impact factor: 7.045
Authors: S Jafari-Sfidvajani; R Ahangari; M Hozoori; H Mozaffari-Khosravi; H Fallahzadeh; A Nadjarzadeh Journal: J Endocrinol Invest Date: 2017-11-06 Impact factor: 4.256
Authors: Dennis T Villareal; Luigi Fontana; Sai Krupa Das; Leanne Redman; Steven R Smith; Edward Saltzman; Connie Bales; James Rochon; Carl Pieper; Megan Huang; Michael Lewis; Ann V Schwartz Journal: J Bone Miner Res Date: 2015-09-24 Impact factor: 6.741